These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8413760)

  • 1. [Modification of cognitive disorders in schizophrenic and schizoaffective psychoses using cognitive therapy in comparison with sociotherapy].
    Theilemann S
    Nervenarzt; 1993 Sep; 64(9):587-93. PubMed ID: 8413760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychometric differentiation of schizophrenic and schizoaffective psychoses].
    Bühler KE; Gross M; Jürgensen R
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(6):535-52. PubMed ID: 1722906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new computerized cognitive and social cognition training specifically designed for patients with schizophrenia/schizoaffective disorder in early stages of illness: A pilot study.
    Fernandez-Gonzalo S; Turon M; Jodar M; Pousa E; Hernandez Rambla C; García R; Palao D
    Psychiatry Res; 2015 Aug; 228(3):501-9. PubMed ID: 26163731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should measurement of cognition be part of recovery programs for patients with Psychotic Illness?
    Agius M; Zaytseva Y
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S486-8. PubMed ID: 26417823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive enhancement therapy with work therapy: effects on neuropsychological test performance.
    Bell M; Bryson G; Greig T; Corcoran C; Wexler BE
    Arch Gen Psychiatry; 2001 Aug; 58(8):763-8. PubMed ID: 11483142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of integrated supported employment plus cognitive remediation training for people with schizophrenia and schizoaffective disorders.
    Au DW; Tsang HW; So WW; Bell MD; Cheung V; Yiu MG; Tam KL; Lee GT
    Schizophr Res; 2015 Aug; 166(1-3):297-303. PubMed ID: 26044114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cognitive performance in RDC-diagnosed schizoaffective and schizophrenic patients with the Luria-Nebraska Neuropsychological Battery.
    Miller LS; Swanson-Green T; Moses JA; Faustman WO
    J Psychiatr Res; 1996; 30(4):277-82. PubMed ID: 8905536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study.
    Bora E; Yucel M; Pantelis C
    Br J Psychiatry; 2009 Dec; 195(6):475-82. PubMed ID: 19949193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The logical and psychometric prerequisites for cognitive therapy of schizophrenia.
    Spaulding W; Garbin CP; Crinean WJ
    Br J Psychiatry Suppl; 1989 Jul; (5):69-73. PubMed ID: 2605026
    [No Abstract]   [Full Text] [Related]  

  • 12. Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial.
    Keefe RS; Vinogradov S; Medalia A; Buckley PF; Caroff SN; D'Souza DC; Harvey PD; Graham KA; Hamer RM; Marder SM; Miller DD; Olson SJ; Patel JK; Velligan D; Walker TM; Haim AJ; Stroup TS
    J Clin Psychiatry; 2012 Jul; 73(7):1016-22. PubMed ID: 22687548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durability and mechanism of effects of cognitive enhancement therapy.
    Hogarty GE; Greenwald DP; Eack SM
    Psychiatr Serv; 2006 Dec; 57(12):1751-7. PubMed ID: 17158490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Timing and effectiveness of Brenner's IPT cognitive training in early psychosis. A pilot study].
    Borriello A; Balbi A; Menichincheri RM; Mirabella F
    Riv Psichiatr; 2015; 50(3):127-33. PubMed ID: 26156818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive growth charts and psychosis: is the relationship predictive?
    Cannon TD
    JAMA Psychiatry; 2014 Apr; 71(4):361-2. PubMed ID: 24499862
    [No Abstract]   [Full Text] [Related]  

  • 16. Two-year follow-up of cognitive functions in schizophrenia spectrum disorders of adolescent patients treated with electroconvulsive therapy.
    de la Serna E; Flamarique I; Castro-Fornieles J; Pons A; Puig O; Andrés-Perpiña S; Lázaro L; Garrido JM; Bernardo M; Baeza I
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):611-9. PubMed ID: 22136098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive abnormalities in schizophrenia and schizophrenia-like psychosis of epilepsy.
    Nathaniel-James DA; Brown RG; Maier M; Mellers J; Toone B; Ron MA
    J Neuropsychiatry Clin Neurosci; 2004; 16(4):472-9. PubMed ID: 15616174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-assisted cognitive rehabilitation reduces negative symptoms in the severely mentally ill.
    Bellucci DM; Glaberman K; Haslam N
    Schizophr Res; 2003 Feb; 59(2-3):225-32. PubMed ID: 12414079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Enhancement Treatment for People With Mental Illness Who Do Not Respond to Supported Employment: A Randomized Controlled Trial.
    McGurk SR; Mueser KT; Xie H; Welsh J; Kaiser S; Drake RE; Becker DR; Bailey E; Fraser G; Wolfe R; McHugo GJ
    Am J Psychiatry; 2015 Sep; 172(9):852-61. PubMed ID: 25998278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are schizophrenia and schizoaffective disorder neuropsychologically distinguishable?
    Heinrichs RW; Ammari N; McDermid Vaz S; Miles AA
    Schizophr Res; 2008 Feb; 99(1-3):149-54. PubMed ID: 18031992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.